Cerecin
Healthcare company that develops a novel evidence-based therapeutics, and products that aim to help people.
Launch date
Employees
Market cap
-
Enterprise valuation
$160—240m (Dealroom.co estimates Aug 2022.)
Denver Colorado (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €9.5m | Early VC | |
| N/A | $10.0m | Early VC | |
$40.0m | Series A | ||
* | $40.0m | Series B | |
| Total Funding | $100m | ||
Related Content
Recent News about Cerecin
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.